[
  {
    "info": {
      "NCT": "NCT05144009",
      "Protocol_No": "ADCT-402-203ADC Therapeutics_ADCT-402-203 (LOTIS-9)",
      "jit": "Avera Trials",
      "trial_name": "LOTIS-9"
    },
    "disease": {
      "summary": "Diffuse Large B-cell Lymphoma (DLBCL)",
      "details": [
        {
          "code": "Diffuse Large B-Cell Lymphoma, NOS (DLBCLNOS)",
          "selection": "include",
          "stage": "Stage I;Stage II;Stage III;Stage IV"
        }
      ]
    },
    "query": {
      "nct": "NCT05144009",
      "title": "A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)",
      "current_status": "Recruiting",
      "status_verif_date": "April 2023",
      "last_update_date": "April 27, 2023",
      "trial_hold_status": "open",
      "sponsor": "ADC Therapeutics S.A.",
      "brief_summary": "The main objective of the trial is to assess the efficacy and tolerability of Lonca-R in unfit and frail participants with previously untreated DLBCL.",
      "conditions": "Diffuse Large B-cell Lymphoma",
      "type": "Interventional",
      "phase": "Phase 2",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Cohort A : Loncastuximab Tesirine + Rituximab (Lonca-R)",
          "drug": "Loncastuximab Tesirine | Rituximab",
          "arm_type": "Experimental",
          "biomarker": [
            {
              "cohort": "Cohort A : Loncastuximab Tesirine + Rituximab (Lonca-R)",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "Not available",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "absent"
	    }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Cohort B : Loncastuximab Tesirine + Rituximab (Lonca-R)",
          "drug": "Loncastuximab Tesirine | Rituximab",
          "arm_type": "Experimental",
          "line_of_therapy": "2",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Cohort B : Loncastuximab Tesirine + Rituximab (Lonca-R)",
              "Gene": "Not available",
              "Gene2": "Not available",
              "Type": "Not available",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Not available",
              "summary": "absent"
            }
          ]
        }
      ],
      "docs": "<a href=\"https://avera-ereg-prod.forteresearchapps.com/ereg-web/protocols/2142/section-4857\" target=\"_blank\">eREG<\/a>",
      "doclastupdate": "2023-05-11",
      "locations": "Sioux Falls SD",
      "min_age": "80 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT05144009\" target=\"_blank\">NCT05144009<\/a>"
    }
  }
]
